Thomas Knott
Chief Executive Officer at Cytocentrics Bioscience GmbH
Profile
Thomas Knott was the founder of Cytocentrics AG, which was founded in 2001, where he held the title of Managing Director-Research & Development in 2013.
He is currently the Managing Director at Cytocentrics Bioscience GmbH since 2017.
Dr. Knott was also the Chief Science Officer at InventaBiotech, Inc. in 2018.
He received his undergraduate and doctorate degrees from Eberhard Karls Universität Tübingen.
Thomas Knott active positions
| Companies | Position | Start |
|---|---|---|
Cytocentrics Bioscience GmbH
 Cytocentrics Bioscience GmbH Pharmaceuticals: MajorHealth Technology Cytocentrics Bioscience GmbH is a German pharmaceutical manufacturing company. The private company is based in Cologne, Germany. The company was founded in 2011. Thomas Knott has been the CEO of the company since 2017. | Chief Executive Officer | 19/06/2017 |
Former positions of Thomas Knott
| Companies | Position | End |
|---|---|---|
Cytocentrics AG
 Cytocentrics AG Medical/Nursing ServicesHealth Services Cytocentrics AG provides a tool for automated patch-clamp and ion channel screening services for drug research. Its products include CytoPatch, CytoPatch Chip, Cell Lines, Microsieves, Microchip, MEA, CP software, cell reservoir and instant cells. The firm's services include device service, cell line development, instant cells, screening services, specific assay development, GLP screening, micro systems technology and assay development for standardizes cell liners. Cytocentrics has locations in Germany and Netherlands. The company was founded in 2001 by Thomas Knott and Alfred Stett and is headquartered in Rostock, Germany. | Founder | 08/03/2013 |
| INVENTABIOTECH INC. | Chief Tech/Sci/R&D Officer | - |
Training of Thomas Knott
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Cytocentrics AG
Cytocentrics AG Medical/Nursing ServicesHealth Services Cytocentrics AG provides a tool for automated patch-clamp and ion channel screening services for drug research. Its products include CytoPatch, CytoPatch Chip, Cell Lines, Microsieves, Microchip, MEA, CP software, cell reservoir and instant cells. The firm's services include device service, cell line development, instant cells, screening services, specific assay development, GLP screening, micro systems technology and assay development for standardizes cell liners. Cytocentrics has locations in Germany and Netherlands. The company was founded in 2001 by Thomas Knott and Alfred Stett and is headquartered in Rostock, Germany. | Health Services |
InventaBiotech, Inc.
 InventaBiotech, Inc. Miscellaneous Commercial ServicesCommercial Services InventaBiotech, Inc. operated as a marketing, media, and investor relations consultant to public and private companies. The company was founded on October 18, 2007 and was headquartered in San Antonio, TX. | Commercial Services |
Cytocentrics Bioscience GmbH
Cytocentrics Bioscience GmbH Pharmaceuticals: MajorHealth Technology Cytocentrics Bioscience GmbH is a German pharmaceutical manufacturing company. The private company is based in Cologne, Germany. The company was founded in 2011. Thomas Knott has been the CEO of the company since 2017. | Health Technology |
- Stock Market
- Insiders
- Thomas Knott
